DIABETES PATIENT AND MYOCARDIAL REVASCULARIZATION FROM THE EVIDENCE GUIDED PERSPECTIVE: CARDIOLOGIST OPINION. PART 2

Abstract

The review focuses on the recent state of the prescription problem of glucose lowering medications in perioperational period for myocardial revascularization in diabetes patients. The positions provided, from current clinical guidelines of the main societies on diabetes and cardiovascular diseases investigation, as the issues highlighted that are not evident enough yet. Studies results described of different strategies for this category of patients management. The significance is shown, of the importance of glucose metabolism compensation in myocardial revascularization, and the fact confirmed, that too strict glycemia control is not beneficial for neither percutaneous, nor open coronary intervention. Main glucose lowering drugs groups are described in an aspect of their influence on cardiovascular system according to the data from the completed trials. The significance is proved of a complex control for the main risk factors in diabetes patients during coronary intervention.

Keywords

• diabetes mellitus
• percutaneous coronary intervention
• coronary artery bypass surgery
• perioperative management
• hypoglycemic therapy